- Home
- DRCT vs BFRI Comparison
DRCT vs BFRI Comparison
Compare DRCT & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRCT | BFRI |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 8.4M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DRCT | BFRI |
|---|---|---|
| Price | $1.57 | $0.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $330.00 | $2.75 |
| AVG Volume (30 Days) | ★ 7.2M | 833.2K |
| Earning Date | 03-26-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $35,369,000.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $11.37 |
| Revenue Next Year | $58.17 | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.11 |
| 52 Week Low | $1.45 | $0.54 |
| 52 Week High | $80.30 | $1.19 |
Technical Indicators
Market Signals| Indicator | DRCT | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 37.63 |
| Support Level | $1.45 | $0.65 |
| Resistance Level | $1.96 | $0.85 |
| Average True Range (ATR) | 0.47 | 0.08 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 4.26 | 32.91 |
Price Performance
Historical ComparisonAbout DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.